BioCentury
ARTICLE | Financial News

Apricus Biosciences completes direct public offering

March 7, 2016 8:00 AM UTC

Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Business: Drug delivery, Genitourinary, Cancer Date completed: 2016-03-04 Type: Direct public offering Raised: $7.8 million Shares: 8.8 millio...